Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
New Study Suggests GlycoMark® May Identify Highest Risk Patients with Prediabetes
2020-09-22 19:00
TCM Lianhua Qingwen Capsule approved for registration in Mauritius
2020-09-22 15:21
Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors
2020-09-21 20:12
Hyde Engineering + Consulting Announces New VP of Global Engineering
2020-09-21 11:30
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
2020-09-21 10:35
Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
2020-09-21 08:00
Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
2020-09-21 08:00
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
2020-09-18 15:00
First patient in treatment in RhoVac's clinical phase IIb study in Sweden
2020-09-17 23:51
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
2020-09-17 20:25
Alter Pharma Group Adopts Movilitas.Cloud to Ensure Safer Goods and EU FMD Compliance Throughout the Product Path and Changes in Packaging
2020-09-16 21:39
Sanofi partners with Health2Sync to deliver an innovative digital solution to patients and healthcare providers, paving the way for digital therapeutics in diabetes
2020-09-16 19:12
CIRT-EU Registry for SIR-Spheres(R) Therapy presented at CIRSE 2020 Summit
2020-09-15 20:00
Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction
2020-09-15 18:05
Elekta introduces new radiotherapy solution to help address worldwide cancer burden
2020-09-15 18:03
MAGHREB PHARMA Expo to contribute to Algeria plans to export for US$ 5 billion locally produced drugs by 2025
2020-09-15 14:00
Standigm Partners with Excelra for GOSTAR to Enhance its AI-driven Drug Discovery Process
2020-09-15 10:00
Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
2020-09-15 03:41
TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
2020-09-14 20:35
Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Granted Orphan Drug Designation by the FDA for the Treatment of Gastric Cancer
2020-09-14 18:35